Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial. (linkinghub.elsevier.com)

Authors: Abizaid A … Morice MC Journal: The Lancet Published: 2026-01-17 DOI: https://doi.org/10.1016/S0140-6736(25)02157-9